Get the Stockscreener App
183.99
1.28%
2.33
After Hours:
183.99
Davita Inc stock is traded at $183.99, with a volume of 449.42K.
It is up +1.28% in the last 24 hours and down -19.30% over the past month.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
See More
Previous Close:
$181.66
Open:
$180.97
24h Volume:
449.42K
Relative Volume:
0.56
Market Cap:
$11.74B
Revenue:
$13.84B
Net Income/Loss:
$1.10B
P/E Ratio:
17.66
EPS:
10.4185
Net Cash Flow:
$1.49B
1W Performance:
+1.83%
1M Performance:
-19.30%
6M Performance:
+18.86%
1Y Performance:
+35.73%
1-Day Range:
$179.95
$184.13
1-Week Range:
$175.47
$184.13
52-Week Range:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
183.99 | 11.18B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
405.00 | 87.96B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
265.05 | 21.95B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.66 | 12.47B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
121.79 | 11.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
DaVita Inc. stock gains support from solid Q2 2026 earnings - AD HOC NEWS
DaVita Inc. (DVA) Stock Analysis: Evaluating the 18.72% Upside Potential for Healthcare Investors - DirectorsTalk Interviews
DaVita Inc. stock gains on solid Q1 figures and buybacks - AD HOC NEWS
DaVita $15M Data Breach Settlement Hits 2.4M Patients - tech-insider.org
DaVita stock gains as Humana expands kidney care - AD HOC NEWS
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks - Seeking Alpha
DaVita $15M Data Breach Settlement 2026: What It Pays - shattered.io
NewsDaVita to pay $15 million to settle data breach lawsuit affecting millions of dialysis patients - teiss
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Eastern Progress
DaVita Reaches Preliminary Settlement Class Agreement Following Ransomware Attack - TradingView
DaVita (DVA) Has Investors Asking A Fresh Question - Yahoo Finance
DaVita Inc. stock gains support from higher earnings and steady guidance - AD HOC NEWS
DaVita (DVA) Q2 2026 Earnings Call Transcript - Fortune
DaVita agrees to pay $15M to settle claims from data breach - medtechdive.com
DaVita Inc. stock holds near 179 dollars after strong 2026 earnings momentum - AD HOC NEWS
Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report? - Yahoo Finance
Do Options Traders Know Something About DaVita Stock We Don't? - TradingView
DaVita Community Care Report 2025: Leading With Integrity and Accountability - CSRwire
DaVita Inc. stock gains after data breach settlement and partnership expansion - AD HOC NEWS
DaVita stock trades around $180 as Q2 2026 growth and kidney-care partnership shape expectations - AD HOC NEWS
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna Healthcare - Yahoo Finance
DaVita Inc. (DVA) Stock Analysis: Strong EPS and Growth Potential Highlight Investment Opportunity - DirectorsTalk Interviews
At US$180, Is DaVita Inc. (NYSE:DVA) Worth Looking At Closely? - Moomoo
Will DaVita’s (DVA) Expanded Humana CKD Partnership Reshape Its Value-Based Care Narrative? - simplywall.st
Enterprise value to revenue forward of DaVita Inc. – NYSE:DVA - TradingView
Davita Inc. Announces New Value-Based Partnership with Humana Inc. to Expand Care for Patients with Chronic Kidney Disease - marketscreener.com
DaVita partners with Humana on kidney disease care program - Investing.com
DaVita Defeats Nurse Overtime Collective Bid - Law360
DaVita Inc. (DVA) Stock Analysis: Potential 25.66% Upside For Healthcare Investors - DirectorsTalk Interviews
DaVita dialysis clinic in Novi has repeated deficiencies as families demand answers after 2 deaths - WXYZ Channel 7
Wealthfront Advisers LLC Buys Shares of 10,596 DaVita Inc. $DVA - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in DaVita Inc. $DVA - MarketBeat
Danske Bank A S Invests $13.11 Million in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita stock steadies after Q2 revenue growth but EPS outlook disappoints - Ad-hoc-news.de
Patients Share Their Experiences With Expanded HD - DaVita Newsroom
DaVita (DVA) Financial Results: EPS Exceeds Its Estimate on the Day; Market Response: The Stock Loses 0.36%Strong Earnings Momentum - Vinanet
DaVita stock slips after Q2 revenue beats forecasts - Ad-hoc-news.de
DaVita (NYSE: DVA) reports new insider stock trade - Stock Titan
DaVita (NYSE: DVA) director Phyllis Yale gets 278-share stock award - Stock Titan
DaVita (NYSE: DVA) insider logs new stock trade in SEC filing - Stock Titan
DaVita (NYSE: DVA) director now holds 5,970 shares after award - Stock Titan
Forever Committed to Excellence in Care: DaVita Community Care Report 2025 - CSRwire
News by ACCESS Newswire on TradingView, 2026-08-18 - TradingView
DaVita Inc. (DVA) Stock Analysis: A Strong ROE And 21% Potential Upside - DirectorsTalk Interviews
Enterprise value to revenue forward of DaVita Inc. – BX:TRL - TradingView
Stronger Q2 Earnings and Transplant Focus Might Change The Case For Investing In DaVita (DVA) - simplywall.st
Bank of America Corp DE Cuts Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Davita Inc Stock (DVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Waters Kathleen Alyce | Chief Legal & Pub. Affairs Off |
Jun 15 '26 |
Sale |
208.40 |
15,405 |
3,210,377 |
109,194 |
| Rodriguez Javier | Chief Executive Officer |
Jun 16 '26 |
Sale |
209.28 |
39,407 |
8,247,018 |
840,408 |
| Rodriguez Javier | Chief Executive Officer |
Jun 15 '26 |
Sale |
209.50 |
30,000 |
6,285,090 |
879,815 |
0.65%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):